Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,915 | 106,728 | 78,868 | 60,360 | 61,666 |
| Marketable Securities | N/A | N/A | N/A | N/A | 35,000 |
| Receivables | 120,080 | 115,107 | 111,498 | 108,384 | 81,389 |
| Inventories | 127,885 | 110,425 | 115,926 | 98,804 | 95,996 |
| Income taxes - deferred | 26,203 | 25,188 | 21,477 | 23,606 | 16,884 |
| Other current assets | 29,508 | 18,890 | 28,121 | 14,509 | 11,328 |
| TOTAL | $460,591 | $376,338 | $355,890 | $305,663 | $302,263 |
| Non-Current Assets | |||||
| PPE Net | 201,725 | 199,946 | 189,646 | 141,852 | 99,628 |
| Intangibles | 55,752 | 212,612 | 207,095 | 236,414 | 157,669 |
| Other Non-Current Assets | 179,076 | 19,631 | 12,806 | 18,250 | 0 |
| TOTAL | $436,553 | $432,189 | $409,547 | $396,516 | $257,297 |
| Total Assets | $897,144 | $808,527 | $765,437 | $702,179 | $559,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 863 | 813 | 765 | 720 | 678 |
| Accounts payable and accrued liabilities | 22,669 | 19,133 | 28,006 | 32,510 | 24,374 |
| Accrued Expenses | 118,598 | 104,959 | 91,292 | 89,042 | 72,250 |
| TOTAL | $285,112 | $256,305 | $295,292 | $223,392 | $124,743 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,418 | 4,281 | 5,094 | 5,727 | 6,447 |
| Deferred Revenues | 13,983 | 12,610 | 11,285 | 10,678 | 8,976 |
| Other Non-Current Liabilities | 11,009 | 11,256 | 11,137 | 13,830 | 4,521 |
| TOTAL | $37,751 | $37,643 | $31,951 | $40,464 | $24,956 |
| Total Liabilities | $322,863 | $293,948 | $327,243 | $263,856 | $149,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,671 | 116,123 | 118,258 | 121,909 | 124,554 |
| Common Shares | 9,797 | 9,633 | 9,539 | 9,450 | 9,324 |
| Retained earnings | 965,540 | 824,256 | 702,031 | 585,862 | 490,614 |
| Other shareholders' equity | 18,299 | 14,893 | 8,932 | 25,238 | 12,592 |
| TOTAL | $574,281 | $514,579 | $438,194 | $438,323 | $409,861 |
| Total Liabilities And Equity | $897,144 | $808,527 | $765,437 | $702,179 | $559,560 |